Sequoia Vaccines, Inc. (SQVI)

Sequoia Vaccines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.71	0.31	2.22
Cash & Cash Equivalents	0.71	0.31	2.22
Cash Growth	-	-86.22%	-
Other Current Assets	0.25	0.25	0.13
Total Current Assets	0.97	0.56	2.36
Property, Plant & Equipment	-	0.03	0.04
Goodwill and Intangibles	-	0.1	0.15
Other Long-Term Assets	-	0.2	0.2
Total Long-Term Assets	-	0.33	0.39
Total Assets	-	0.89	2.75
Accounts Payable	-	0.32	0.15
Current Debt	-	0.09	0.08
Other Current Liabilities	0.55	0.07	0.08
Total Current Liabilities	0.55	0.48	0.31
Long-Term Debt	-	1.05	1.12
Other Long-Term Liabilities	-	0.38	0.29
Total Long-Term Liabilities	-	1.43	1.41
Total Liabilities	-	1.91	1.72
Total Debt	1.07	1.14	1.21
Debt Growth	-	-5.85%	-
Retained Earnings	-	-53.45	-49.26
Shareholders' Equity	-21.78	-19.59	-15.45
Net Cash / Debt	-0.36	-0.83	1.02
Working Capital	0.42	0.08	2.05

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).